Director/PDMR Shareholding

GlaxoSmithKline PLC 19 July 2006 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in the interests of Directors, Persons Discharging Managerial Responsibility or Connected Persons in the Ordinary Shares of GlaxoSmithKline plc. 17 July 2006 Abacus (GSK) Trustees Limited, as trustee of the GlaxoSmithKline Employee Trust, ("the GSK Trust"), sold 574 Ordinary Shares in the Company on behalf of participants in the GlaxoSmithKline Performance Share Plan at a price of £14.634 per share. The GSK Trust transferred 1,871 Ordinary Shares in the Company to participants in the GlaxoSmithKline Performance Share Plan. 18 July 2006 The GSK Trust transferred 8,135 Ordinary Shares in the Company to participants in the SmithKline Beecham Employee Share Option Plan 1991. 19 July 2006 The GSK Trust sold 1,992 Ordinary Shares in the Company on behalf of participants in the GlaxoSmithKline Share Value Plan at a price of £14.8525 per share. The GSK Trust transferred 10,489 Ordinary Shares in the Company to participants in the GlaxoSmithKline Share Value Plan. The Company was advised of these transactions on 19 July 2006. The GSK Trust is a discretionary trust of which all employees or former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. Three of the Company's directors, Dr J-P Garnier, Dr M M Slaoui and Mr J S Heslop are therefore interested in the shares held in the GSK Trust from time to time in the same way as other employees or former employees of GlaxoSmithKline plc and its subsidiaries. This notification relates to a transaction notified in accordance with Disclosure Rule 3.1.4R(1)(b). S M Bicknell Company Secretary 19 July 2006 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings